Germline mutations of the MEN1 gene in familial multiple endocrine neoplasia type 1 and related states

Human Molecular Genetics

Volumn 6, Issue 7, 1997, Pages 1169-1175

  Agarwal, Sunita K ^e   Kester, Mary Beth ^e   Debelenko, Larisa V ^a   Heppner, Christina ^e   Emmert Buck, Michael R ^a   Skarulis, Monica C ^e   Doppman, John L ^b   Kim, Young S ^e   Lubensky, Irina A ^a   Zhuang, Zhengping ^a   Green, Jane S ^c   Guru, Sirandanahalli C ^d   Manickam, Pachiappan ^d   Olufemi, Shodimu Emmanuel ^d   Liotta, Lance A ^a   Chandrasekharappa, Settara C ^d   Collins, Francis S ^d   Spiegel, Allen M ^e   Lee Burns, A ^e   Marx, Stephen J ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Diagnostic Radiology Department   (United States)

^c Health Sciences Centre   (Canada)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

ARTICLE; GENE MUTATION; GERM LINE; HETEROZYGOSITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE ENDOCRINE NEOPLASIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADULT; AGED; GERM-LINE MUTATION; HUMANS; HYPERPARATHYROIDISM; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM PROTEINS; PEDIGREE; POLYMORPHISM, GENETIC; PROTO-ONCOGENE PROTEINS;

EID: 8544279953     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/6.7.1169     Document Type: Article

References (31)

1. Wermer, P. (1954) Genetic aspects of adenomatosis of endocrine glands. Am. J. Med. 16, 363-371.
2. Ballard, H.S., Frame, B. and Hartsock, R.J. (1964) Familial multiple endocrine adenoma peptic ulcer complex. Am. J. Med. 43, 481-516.
3. Metz, D.C., Jensen, R.T., Bale, A., Skarulis, M.C., Eastman, R.C., Nieman, L., Norton, J.A., Friedman, E., Larsson, C., Amorosi, A., Brandi, M.L. and Marx, S.J. (1994) Multiple endocrine neoplasia type 1 : Clinical features and management. In Bilezekain, J.P., Levine, M.A. and Marcus, R. (eds) The Parathyroids. Raven Press, New York, pp. 591-646.
4. Larsson, C., Calender, A., Grimmond, S., Giraud, S., Hay ward, N.K., Teh, B. and Farnebo, F. (1995) Molecular tools for presymptomatic testing in multiple endocrine neoplasia type 1. J. Intern. Med. 238, 239-244.
5. Marx, S.J., Attie, M.F., Spiegel, A.M., Levine, M.A., Lasker, R.D. and Fox, M. (1982) Familial hypocalciuric hypercalcemia: the relation to primary parathyroid hyperplasia. N. Engl. J. Med. 307, 416-426.
6. Kassem, M., Zhang, X., Brask, S., Eriksen, E.F., Mosekilde, L. and Kruse, T.A. (1994) Familial isolated primary hyperparathyroidism. Clin. Endocrinol. 41, 415-420.
7. Stock, J.L., Warth, M.R., Teh, B.T., Coderre, J.A., Overdorf, J.H. Baumann, G., Hintz, R.L., Hartman, M.L., Seizinger, B.R., Larsson, C. and Aronin, N. (1997) A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus on chromosome region 11q13. J. Clin. Endocrinol. Metab. 82, 468-492.
8. Chandrasekharrapa, S.C., Guru, S.C., Manickam, P., Olufemi, S.E., Collins, F.S., Emmert-Buck, M.R., Debelenko, L.V, Zhuang, Z., Lubensky, I.A., Liotta, L.A., Crabtree, J.S., Wang, W., Roe, B.A., Weisemann, J., Boguski, M.S., Agarwal, S.K., Kester, M.B., Kim, Y.S., Heppner, C., Dong, Q., Spiegel, A.M., Burns, A.L. and Marx, S.J. (1997) Positional cloning of the gene for multiple endocrine neoplasia type 1. Science 276, 404-407.
9. Marx, S.J., Powell, D., Shimkin, P., Wells, S.A., Ketcham, A.S., McGuigan, J.E., Bilezekian, J.P. and Aurbach, G.D. (1973) Familial hyperparathyroidism: mild hypercalcemia in at least nine members of a kindred. Ann. Int. Med. 78, 371-377.
10. Hershon, K.S., Kelly, W.A., Shaw, C.M., Schwartz, R. and Bierman, E.L. (1983) Prolactinomas as part of multiple endocrine neoplastic syndrome type 1. Am. J. Med. 74, 713-720.
11. Petty, E.M., Green, J.S., Marx, S.J., Taggart, R. T., Farid, N. and Bale, A.E. (1994) Mapping the gene for hereditary hyperparathyroidism and prolactinoma (MEN1-Burin) to chromosome 11q: evidence for a founder effect in patients from Newfoundland. Am. J Hum. Genet. 54, 1060-1066.
12. Green, J.S. (1995) Development, implementation and evaluation of clinical and genetic screening programs for hereditary tumor syndromes. Ph.D. Thesis, Memorial University, Newfoundland, Canada.
13. Lucotte, G. and Hazout, S. (1995) Geographic and ethnic distributions of the more frequent cystic fibrosis mutations in Europe show that a founder effect is apparent for several mutant alleles. Hum. Biol. 67, 562-576.
14. Sarkar, G., Yoon, H.S. and Sommer, S.S. (1992) Dideoxyfingerprinting: a rapid and efficient screen for the presence of mutations. Genomics 13, 441-443.
15. Liu, Q. and Sommer, S.S. (1994) Parameters affecting sensitivities of dideoxyfingerprinting and SSCP. PCR Methods Applications 4, 97-100.
16. Antonarakis, S.A. (1996) Mutations in human diseases: nature and consequences. In Rimoin, D.L., Connor, J.M., and Pyeritz, R.E. (eds) Emery and Rimoin's Principles and Practices of Medical Genetics. Churchill Livingstone, New York, 53-66.
17. Heath, H. III, Hodgson, S.F. and Kennedy, M.A. (1980) Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 302, 189-193.
18. Marx, S.J., Menczel, J., Campbell, G, Aurbach, G.D., Spiegel, A.M. and Norton, J. A. (1991) Heterogeneous size of the parathyroid glands in familial mutiple endocrine neoplasia type 1. Clin. Endocrinol. 35, 521-526.
19. Trump, D., Farren, B., Wooding, C., Pang, J.T., Besser, G.M., Buchanan, K.D., Edwards, C.R., Heath, D.A., Jackson, C.E., Lips, K., Monson, J.P., O'Halloran, D., Sampson, J., Shalet S.M., Wheeler, M.H., Zink, A. and Thakker, R. V. (1996) Clinical studies of multiple endocrine neoplasia type 1 (MEN1). Q. J. Med. 89, 653-659.
20. Dong, Q., Debelenko, L.V., Chandrasekharappa, S.C., Emmert-Buck, M.R., Zhuang, Z., Guru, S.C., Manickam, P., Skarulis, M., Lubensky, I.A., Liotta, L.A., Collins, F.S., Marx, S.J. and Spiegel, A.M. (1997) Loss of heterozygosity at 11q13: analysis of pituitary tumors, lung carcinoids, lipomas, and other uncommon tumors in subjects with familial multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 82, 1416-1420.
21. Teh, B.T., Farnebo, F., Kristoffersson, U., Sundelin, B., Cardinal, J., Axelson, R., Yap, A., Epstein, M., Heath, H. III, Cameron, D. and Larsson, C. (1996) Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J. Clin. Endocrinol. Metab. 81, 4204-4211.
22. 2+-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am. J Hum. Genet. 56, 1075-1079.
23. Heath, H., III, Jackson, C.E., Otterud, B. and Leppert, M.F. (1993) Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am. J. Hum. Genet. 53, 193-200.
24. Larsson, C., Skogseid, B., Oberg, K., Nakamura, Y. and Nordenskjold, M. (1988) Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma. Nature 332, 85-87.
25. Ishioka, C., Suzuki, T., Fitzgerald, M., Krainer, M., Shimodaira, H., Shimada, A., Nomizu, T., Isselbacher, K.J., Haber, D. and Kanamaru, R. (1997) Detection of heterozygous truncating mutations in the BRCA1 and APC genes by using a rapid screening assay in yeast. Proc. Natl. Acad. Sci. USA 94, 2449-2453.
26. Wooton, J. (1996) Analysis of compositionally biased regions in sequence databases. Meth. Enzymol. 266, 554-571.
27. Cottingham, R.W., Idury, R.M. and Schaffer, A.A. (1993) Faster sequential genetic linkage compilations. Am. J. Hum. Genet. 53, 252-263.
28. Debelenko, L.V., Emmert-Buck, M.R., Manickam, P., Kester M.B., Guru, S.C., DiFranco, E.M., Olufemi, S.-E., Agarwal, S., Lubensky, I.A., Zhuang, Z., Burns, A.L., Spiegel, A.M., Liotta, L.A., Collins, F.S., Marx, S.J. and Chandrasekharappa, S.C. (1997) Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene. Cane. Res. 57, 1039-1042.
29. Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G. and Lathrop, M. (1992) A second-generation linkage map of the human genome. Nature 359, 794-801.
30. Sainz, J., Rasmussen, M., Nechiporuk, A., Vissing, H., Cheng, X., Korenberg, J.R. and Pulst, S.M. (1993) Dinucleotide repeat polymorphism at the D22S351 locus. Hum. Mol. Genet. 2, 1749.
31. Moffatt, M.F. (1993) Dinucleotide repeat polymorphism at the D11S480 locus. Hum. Mol. Genet. 2, 492.